We need a temporary moratorium on using gene editing to create babies
By Paul Knoepfler,
STAT
| 12. 03. 2018
The rationales for human germline editing don’t make much sense to me. They consist of invoking rare or even hypothetical scenarios where CRISPR might serve some purpose that cannot be achieved by already proven and safe embryo screening methods such as pre-implantation genetic diagnosis.
On a cold, drizzly night almost three years ago, I stood inside the nearly deserted Lincoln Memorial in Washington, D.C., I was in town to attend the first International Summit on Human Gene Editing organized by the National Academy of Sciences and the National Academy of Medicine. After a day of intense talks at the meeting, I had gone for a long walk and found myself looking up at Big Abe. A big question was on my mind: Would the organizers of the meeting call for a moratorium on using CRISPR to make gene-edited babies, as I hoped they would?
They didn’t.
When I learned of that decision, my feeling was that someone would report the creation of the first “CRISPR baby” within the next few years. That might happen even with a moratorium, but the odds had just increased substantially.
Since then, there have been similar meetings around the world about human germline gene editing — editing eggs, sperm, and embryos that are then used to make people — along with official reports from committees. None called for a...
Related Articles
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
